Future studies are required to evaluate the precise mechanism underlying the effect of BIO on the apoptotic process and to identify downstream target proteins in the pathway triggering attenuated cell viability of AML cells with FLT3 mutation. Here, FLT3 is linked to acute myeloid leukemia.